Key takeaways
Symbicort is an inhaler used to treat asthma and COPD, but it may not be right for everyone.
You can consult your healthcare provider about alternatives such as Advair, Dulera, Breo, Breztri, or Trelegy, one of which may be better suited for you.
If you are interested in trying a Symbicort alternative, talk to your healthcare provider. They can help you weigh the pros and cons of different options and consider factors like cost, potential side effects, and dosing preferences.
Symbicort is a combination inhaler that contains two ingredients: budesonide, an inhaled corticosteroid (ICS), and formoterol, a long-acting beta-2 agonist (LABA). It works by reducing inflammation (swelling) in the lungs and relaxing the airways to make breathing easier. Symbicort is used to treat asthma as a maintenance medicine and, in some cases, as a relief medicine. It’s also FDA-approved to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Symbicort may not be appropriate for everyone, especially people with heart problems, osteoporosis, and glaucoma, among other medical conditions. Less commonly, Symbicort can also cause serious side effects, including lung infection and a weakened immune system. In these situations, a healthcare provider may suggest a different medication.
Related: What is Symbicort
What can I take instead of Symbicort?
There are many products available to treat respiratory disorders, and alternative medications may be preferred for some people, depending on individual circumstances, such as certain pre-existing conditions or insurance coverage. Other factors such as side effects, the type of inhaler device, and disease severity may also influence someone to try a Symbicort alternative. Examples of other drugs for the long-term treatment of asthma and COPD are listed below. Another option may be more suitable for you, but you’ll need to consult your healthcare provider for medical advice.
Compare Symbicort alternatives |
|||
|---|---|---|---|
| Drug name | Price without insurance | SingleCare price | Savings options |
| Symbicort (budesonide/formoterol) | $494 for 1, 10.2 gram inhaler (160/4.5 mcg per actuation) | $156 for 1, 10.2 gram inhaler (160/4.5 mcg per actuation) of generic budesonide/formoterol | See latest prices |
| Advair Diskus (fluticasone/salmeterol) | $506 for 1, 250/50 mcg per actuation diskus inhaler | $50 for 1, 250/50 mcg per actuation diskus inhaler of generic fluticasone/salmeterol | See latest prices |
| Advair HFA (fluticasone/salmeterol) | $527 for 1, 12 gram inhaler (115/21 mcg per actuation) | $257 for 1, 12 gram inhaler (115/21 mcg per actuation) of generic fluticasone/salmeterol | See latest prices |
| Dulera (mometasone/formoterol) | $489 for 1, 13 gram inhaler (200/5 mcg per actuation) | $337 for 1, 13 gram inhaler (200/5 mcg per actuation) of brand-name Dulera | See latest prices |
| Breo Ellipta (fluticasone/vilanterol) | $554 for 1, 60 gram inhaler (100/25 mcg per actuation) | $246 for 1, 60 gram inhaler (100/25 mcg per actuation) of generic fluticasone/vilanterol | See latest prices |
| Breztri (budesonide/glycopyrrolate/formoterol) | $902 for 1, 10.7 gram inhaler (160/9/4.8 mcg per actuation) | $553 for 1, 10.7 gram inhaler (160/9/4.8 mcg per actuation) of brand-name Breztri | See latest prices |
| Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) | $917 for 1 inhaler (100/62.5/25 mcg per actuation) | $534 for 1 inhaler (100/62.5/25 mcg per actuation) of brand-name Trelegy Ellipta | See latest prices |
| Singulair (montelukast) | $991 for 90, 10 mg tablets | $9 for 90, 10 mg tablets of generic montelukast | See latest prices |
| Spiriva Respimat (tiotropium) | $97 for 1, 4 gram inhaler (2.5 mcg per actuation) | $62 for 1, 4 gram inhaler (2.5 mcg per actuation) of brand-name Spiriva Respimat | See latest prices |
Prescription drug prices often change. These are the most accurate medication prices at the time of publishing. The listed price without insurance references the price of brand-name drugs (unless otherwise specified). The listed SingleCare price references the price of generic drugs if available. Click the link under “Savings options” to see the latest drug prices.
Top 5 Symbicort alternatives
While many different inhaler medications are available, the following are some of the most common alternatives to Symbicort. Note: Short-acting beta agonists like albuterol are not alternatives to long-acting beta agonists such as Symbicort when used for maintenance treatment of asthma or COPD.
1. Advair
Advair is available as two dosage forms: Advair Diskus and Advair HFA. Advair HFA is an aerosol metered-dose inhaler approved for asthma in adults and pediatric patients 12 years and older. Advair Diskus is a dry powder inhaler approved for both asthma (in adults and children 4 years and older) and COPD. The active ingredients in Advair and Symbicort belong to the same drug classes, but Advair contains different active ingredients (fluticasone/salmeterol). Because Advair and Symbicort are both ICS/LABA combination medications, they have similar side effects such as upper respiratory infection, headache, sinus pain, and oral thrush. (Note: to reduce the risk of oral thrush, you should always rinse your mouth with water and spit after using inhalers with an ICS.) Some patients may find the Advair Diskus inhaler easier to use because it requires less hand-breath coordination than Symbicort. Advair Diskus is typically given at a dose of one inhalation twice daily and Advair HFA as two inhalations twice daily.
RELATED: Symbicort vs. Advair
2. Dulera
Dulera is an asthma medication in the same drug class as Symbicort. Dulera contains the ICS mometasone and the LABA formoterol. Dulera and Symbicort share the same bronchodilator ingredient. While Symbicort is FDA-approved to treat asthma and COPD, Dulera is only indicated for the treatment of asthma in adults and children 5 years and older. In clinical studies, these medications have been found to be effective for asthma by improving quality of life and reducing asthma attacks. Dulera and Symbicort also have similar side effect profiles and dosing schedules of two inhalations twice daily.
3. Breo Ellipta
Breo Ellipta is another ICS/LABA combination inhaler containing fluticasone and vilanterol. Breo is indicated for the long-term treatment of asthma (in adults and children 5 years and older) and COPD. In a clinical study comparing the effects of Breo versus Symbicort in asthma patients, both drugs showed similar improvements in lung function. However, Breo—which is given at one inhalation once daily—had better convenience and adherence compared to Symbicort, which is dosed at two inhalations twice daily. This once-daily dosing schedule may be preferable for certain patients.
4. Breztri
Breztri and Symbicort both contain budesonide and formoterol, but Breztri has another added ingredient called glycopyrrolate, making it a triple combination therapy. Glycopyrrolate is an anticholinergic drug that works by relaxing and widening airways in the lungs. Breztri is only indicated for COPD and is not approved for asthma. In a clinical study, the rate of COPD exacerbations was 13% to 14% lower with Breztri than with Symbicort, and both medications had similar rates of side effects such as pneumonia, upper respiratory infection, and bronchitis. Breztri and Symbicort are both dosed at two inhalations twice daily.
5. Trelegy Ellipta
Like Breztri, Trelegy is a triple therapy medication with an ICS (fluticasone), anticholinergic (umeclidinium), and LABA (vilanterol). Trelegy is the first FDA-approved triple therapy for the maintenance treatment of asthma and COPD. Trelegy is not approved for use in children and teenagers under 18 years old. Common side effects of Trelegy include respiratory infection, sore throat, sinusitis, and oral thrush. Compared to Symbicort, Trelegy was shown to reduce COPD exacerbations by 35% more. Trelegy is given at one inhalation once daily.
Natural alternatives to Symbicort
Natural remedies can help patients with asthma and COPD manage their daily symptoms and improve their quality of life. There are multiple non-drug options available, but these therapies usually work best when used along with prescription drugs like Symbicort. And it’s important to note that while certain natural remedies may help, they are not a substitute for prescriptions recommended by your healthcare provider.
Alternative therapies for asthma and COPD include the following treatments, lifestyle modifications, and vitamins:
- Yoga: Breathing exercises practiced in yoga have been found to improve quality of life and reduce asthma symptoms. However, more studies are needed to understand the full effect of yoga in asthma management.
- Reducing environmental triggers: Asthma and COPD symptoms can worsen when individuals are exposed to environmental triggers such as cigarette smoke, air pollution, and dust. Patients who smoke are encouraged to quit and avoid secondhand smoke. Limiting time spent outdoors when the air quality is poor and reducing dust exposure are also recommended.
- Vitamin D: In a meta-analysis examining the role of vitamin D in asthma treatment, vitamin D intake reduced the risk of having an asthma attack requiring hospitalization. Vitamin D deficiency is also common in COPD patients, and supplementation may help ease COPD symptoms.
There is less scientific evidence about the effectiveness of these natural alternatives compared to prescription medicines. Patients should always consult a healthcare professional for medical advice before modifying their treatment plan.
How to switch to a Symbicort alternative
Asthma or COPD that is not optimally controlled by Symbicort may require different or additional medications. Before switching to a Symbicort alternative, it’s important to take the following steps and discuss them with a healthcare provider:
- Do not stop taking Symbicort. Stopping Symbicort abruptly without a replacement treatment can lead to a return or worsening of asthma or COPD symptoms. If your healthcare provider switches you to a different inhaler, follow their instructions carefully on how to stop using Symbicort and start using your new inhaler.
- Keep a symptom diary. A symptom diary is used to record day-to-day disease symptoms. A healthcare provider can use this diary to evaluate how well your treatment is working.
- Keep a record of medication side effects. Record how often you experience Symbicort side effects and if any side effects interfere with daily activities. Call your healthcare provider right away if you have serious or concerning side effects.
- Tell the healthcare provider about any dosing preferences. There are many types of inhaler devices, each with different advantages and disadvantages. Factors to consider when choosing a new inhaler include ease of handling and the choice of a once versus twice daily regimen.
- Ask the healthcare provider about complementary therapies. If you are thinking about adding lifestyle changes or an over-the-counter supplement to your treatment regimen, discuss these options with a healthcare professional first. Don’t change or stop your prescription respiratory medication.
- Check your insurance coverage. Before you switch to a new medication, make sure it’s covered by your insurance plan. If it’s covered but still expensive or if it’s not covered at all, you can always use SingleCare coupons to save on your prescription and refills, too.
Choosing the right path for asthma and COPD treatment
There are various drugs used for asthma and COPD. Some contain one active ingredient, while others combine two or even three drug classes to help control symptoms differently. Consult your healthcare provider for more information and individualized medical advice about which medicine is best for your condition.
- Symbicort, PDR
- Advair, PDR
- Dulera, DailyMed (2025)
- Breo Ellipta, DailyMed (2024)
- Breztri, DailyMed (2022)
- Trelegy Ellipta, DailyMed (2023)
- Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD, Respiratory Medicine (2016)
- Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial, Journal of Asthma and Allergy (2019)
- Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD, The New England Journal of Medicine (2020)
- FULFIL trial: Once-daily triple therapy for patients with chronic obstructive pulmonary disease, American Journal of Respiratory and Critical Care Medicine (2017)
- Yoga for asthma, Cochrane Database of Systematic Reviews (2016)
- Vitamin D for the management of asthma, Cochrane Database of Systematic Reviews (2016)
- Pocket Guide for Asthma Management and Prevention, Global Initiative for Asthma (2023)